nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—TOP2A—breast cancer	0.208	0.745	CbGaD
Podofilox—TUBB—Eribulin—breast cancer	0.0943	0.179	CbGbCtD
Podofilox—TUBB—Ixabepilone—breast cancer	0.0904	0.171	CbGbCtD
Podofilox—CYP3A4—breast cancer	0.0711	0.255	CbGaD
Podofilox—TOP2A—Idarubicin—breast cancer	0.0526	0.0997	CbGbCtD
Podofilox—TUBB—Vinorelbine—breast cancer	0.0483	0.0915	CbGbCtD
Podofilox—NR3C1—Fluoxymesterone—breast cancer	0.0365	0.0691	CbGbCtD
Podofilox—TUBB—Paclitaxel—breast cancer	0.0339	0.0643	CbGbCtD
Podofilox—TUBB—Vinblastine—breast cancer	0.0298	0.0564	CbGbCtD
Podofilox—TUBB—Docetaxel—breast cancer	0.0245	0.0465	CbGbCtD
Podofilox—TOP2A—Mitoxantrone—breast cancer	0.0226	0.0429	CbGbCtD
Podofilox—TOP2A—Epirubicin—breast cancer	0.0183	0.0347	CbGbCtD
Podofilox—TOP2A—Doxorubicin—breast cancer	0.00973	0.0184	CbGbCtD
Podofilox—CYP2C19—Lapatinib—breast cancer	0.00768	0.0145	CbGbCtD
Podofilox—CYP3A4—Exemestane—breast cancer	0.00734	0.0139	CbGbCtD
Podofilox—CYP3A4—Letrozole—breast cancer	0.00624	0.0118	CbGbCtD
Podofilox—CYP3A4—Anastrozole—breast cancer	0.00556	0.0105	CbGbCtD
Podofilox—CYP3A4—Toremifene—breast cancer	0.00509	0.00964	CbGbCtD
Podofilox—CYP3A4—Fulvestrant—breast cancer	0.00473	0.00896	CbGbCtD
Podofilox—CYP3A4—Thiotepa—breast cancer	0.00422	0.00799	CbGbCtD
Podofilox—CYP3A4—Ixabepilone—breast cancer	0.00386	0.00731	CbGbCtD
Podofilox—CYP2C19—Tamoxifen—breast cancer	0.00384	0.00728	CbGbCtD
Podofilox—CYP3A4—Lapatinib—breast cancer	0.00371	0.00703	CbGbCtD
Podofilox—CYP3A4—Raloxifene—breast cancer	0.00281	0.00533	CbGbCtD
Podofilox—CYP3A4—Vinorelbine—breast cancer	0.00206	0.0039	CbGbCtD
Podofilox—TUBA4A—mammary gland—breast cancer	0.00196	0.0655	CbGeAlD
Podofilox—CYP3A4—Tamoxifen—breast cancer	0.00186	0.00352	CbGbCtD
Podofilox—CYP3A4—Mitoxantrone—breast cancer	0.00181	0.00343	CbGbCtD
Podofilox—Teniposide—NCOA1—breast cancer	0.00163	0.325	CrCbGaD
Podofilox—TUBA4A—nipple—breast cancer	0.00162	0.0542	CbGeAlD
Podofilox—CYP3A4—Paclitaxel—breast cancer	0.00145	0.00274	CbGbCtD
Podofilox—CYP3A4—Irinotecan—breast cancer	0.00143	0.0027	CbGbCtD
Podofilox—CYP3A4—Vinblastine—breast cancer	0.00127	0.0024	CbGbCtD
Podofilox—TOP2A—nipple—breast cancer	0.0012	0.0401	CbGeAlD
Podofilox—TUBB—nipple—breast cancer	0.00119	0.0397	CbGeAlD
Podofilox—TUBA4A—Gefitinib—Lapatinib—breast cancer	0.00113	0.391	CbGdCrCtD
Podofilox—Teniposide—NCOA3—breast cancer	0.0011	0.219	CrCbGaD
Podofilox—TUBA4A—epithelium—breast cancer	0.00109	0.0365	CbGeAlD
Podofilox—CYP3A4—Docetaxel—breast cancer	0.00105	0.00198	CbGbCtD
Podofilox—TUBA4A—skin of body—breast cancer	0.00104	0.0347	CbGeAlD
Podofilox—TUBA4A—endometrium—breast cancer	0.000978	0.0327	CbGeAlD
Podofilox—TUBA4A—uterus—breast cancer	0.000901	0.0302	CbGeAlD
Podofilox—TUBA4A—pituitary gland—breast cancer	0.000885	0.0296	CbGeAlD
Podofilox—TUBA4A—adipose tissue—breast cancer	0.000881	0.0295	CbGeAlD
Podofilox—TUBA4A—female reproductive system—breast cancer	0.00081	0.0271	CbGeAlD
Podofilox—TUBA4A—adrenal gland—breast cancer	0.00079	0.0265	CbGeAlD
Podofilox—CYP3A4—Doxorubicin—breast cancer	0.00078	0.00148	CbGbCtD
Podofilox—TUBA4A—bone marrow—breast cancer	0.000765	0.0256	CbGeAlD
Podofilox—TUBA4A—female gonad—breast cancer	0.000737	0.0247	CbGeAlD
Podofilox—TOP2A—endometrium—breast cancer	0.000723	0.0242	CbGeAlD
Podofilox—TUBB—endometrium—breast cancer	0.000717	0.024	CbGeAlD
Podofilox—TUBA4A—endocrine gland—breast cancer	0.000685	0.0229	CbGeAlD
Podofilox—TOP2A—uterus—breast cancer	0.000666	0.0223	CbGeAlD
Podofilox—TUBB—uterus—breast cancer	0.00066	0.0221	CbGeAlD
Podofilox—TOP2A—adipose tissue—breast cancer	0.000652	0.0218	CbGeAlD
Podofilox—TUBB—pituitary gland—breast cancer	0.000649	0.0217	CbGeAlD
Podofilox—TUBB—adipose tissue—breast cancer	0.000646	0.0216	CbGeAlD
Podofilox—TOP2A—adrenal gland—breast cancer	0.000585	0.0196	CbGeAlD
Podofilox—TUBB—adrenal gland—breast cancer	0.000579	0.0194	CbGeAlD
Podofilox—TOP2A—bone marrow—breast cancer	0.000566	0.0189	CbGeAlD
Podofilox—TUBB—bone marrow—breast cancer	0.000561	0.0188	CbGeAlD
Podofilox—NR3C1—nipple—breast cancer	0.00055	0.0184	CbGeAlD
Podofilox—TOP2A—female gonad—breast cancer	0.000545	0.0182	CbGeAlD
Podofilox—TUBB—female gonad—breast cancer	0.00054	0.0181	CbGeAlD
Podofilox—TUBA4A—lymph node—breast cancer	0.000474	0.0159	CbGeAlD
Podofilox—NR3C1—embryo—breast cancer	0.000454	0.0152	CbGeAlD
Podofilox—NR3C1—epithelium—breast cancer	0.00037	0.0124	CbGeAlD
Podofilox—NR3C1—skin of body—breast cancer	0.000352	0.0118	CbGeAlD
Podofilox—TOP2A—lymph node—breast cancer	0.00035	0.0117	CbGeAlD
Podofilox—TUBB—lymph node—breast cancer	0.000347	0.0116	CbGeAlD
Podofilox—NR3C1—endometrium—breast cancer	0.000332	0.0111	CbGeAlD
Podofilox—Teniposide—TOP2A—breast cancer	0.00032	0.0637	CrCbGaD
Podofilox—Etoposide—GSTT1—breast cancer	0.000317	0.0632	CrCbGaD
Podofilox—Etoposide—ABCC1—breast cancer	0.000307	0.0612	CrCbGaD
Podofilox—NR3C1—uterus—breast cancer	0.000306	0.0102	CbGeAlD
Podofilox—NR3C1—pituitary gland—breast cancer	0.0003	0.0101	CbGeAlD
Podofilox—NR3C1—adipose tissue—breast cancer	0.000299	0.01	CbGeAlD
Podofilox—CYP2C19—endocrine gland—breast cancer	0.000298	0.00997	CbGeAlD
Podofilox—NR3C1—female reproductive system—breast cancer	0.000275	0.00921	CbGeAlD
Podofilox—NR3C1—adrenal gland—breast cancer	0.000268	0.00899	CbGeAlD
Podofilox—NR3C1—bone marrow—breast cancer	0.00026	0.00869	CbGeAlD
Podofilox—Etoposide—GSTP1—breast cancer	0.000251	0.05	CrCbGaD
Podofilox—NR3C1—female gonad—breast cancer	0.00025	0.00838	CbGeAlD
Podofilox—Etoposide—TOP2A—breast cancer	0.000237	0.0472	CrCbGaD
Podofilox—NR3C1—endocrine gland—breast cancer	0.000233	0.00779	CbGeAlD
Podofilox—Teniposide—ABCG2—breast cancer	0.000219	0.0435	CrCbGaD
Podofilox—CYP3A4—female reproductive system—breast cancer	0.000208	0.00696	CbGeAlD
Podofilox—TOP2A—Docetaxel—Paclitaxel—breast cancer	0.0002	0.0693	CbGdCrCtD
Podofilox—TOP2A—Gefitinib—Lapatinib—breast cancer	0.000196	0.0679	CbGdCrCtD
Podofilox—CYP3A4—endocrine gland—breast cancer	0.000176	0.00589	CbGeAlD
Podofilox—Etoposide—ABCG2—breast cancer	0.000162	0.0323	CrCbGaD
Podofilox—NR3C1—lymph node—breast cancer	0.000161	0.00539	CbGeAlD
Podofilox—Inflammation—Methotrexate—breast cancer	0.000148	0.00183	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Melphalan—breast cancer	0.000148	0.00183	CcSEcCtD
Podofilox—Dermatitis bullous—Capecitabine—breast cancer	0.000146	0.00181	CcSEcCtD
Podofilox—Erythema—Thiotepa—breast cancer	0.000146	0.0018	CcSEcCtD
Podofilox—Oedema—Tamoxifen—breast cancer	0.000146	0.0018	CcSEcCtD
Podofilox—Haemoglobin—Irinotecan—breast cancer	0.000145	0.0018	CcSEcCtD
Podofilox—Haemoglobin—Mitoxantrone—breast cancer	0.000145	0.0018	CcSEcCtD
Podofilox—Haemorrhage—Irinotecan—breast cancer	0.000145	0.00179	CcSEcCtD
Podofilox—Haemorrhage—Mitoxantrone—breast cancer	0.000145	0.00179	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Goserelin—breast cancer	0.000144	0.00178	CcSEcCtD
Podofilox—Vomiting—Ixabepilone—breast cancer	0.000144	0.00178	CcSEcCtD
Podofilox—Oedema—Melphalan—breast cancer	0.000143	0.00176	CcSEcCtD
Podofilox—TOP2A—Topotecan—Irinotecan—breast cancer	0.000143	0.0493	CbGdCrCtD
Podofilox—Rash—Ixabepilone—breast cancer	0.000142	0.00176	CcSEcCtD
Podofilox—Dermatitis—Ixabepilone—breast cancer	0.000142	0.00176	CcSEcCtD
Podofilox—Ulcer—Epirubicin—breast cancer	0.000142	0.00175	CcSEcCtD
Podofilox—Haemoglobin—Gemcitabine—breast cancer	0.000142	0.00175	CcSEcCtD
Podofilox—Headache—Ixabepilone—breast cancer	0.000142	0.00175	CcSEcCtD
Podofilox—Haemorrhage—Gemcitabine—breast cancer	0.000141	0.00174	CcSEcCtD
Podofilox—Dizziness—Letrozole—breast cancer	0.000141	0.00174	CcSEcCtD
Podofilox—Dizziness—Anastrozole—breast cancer	0.000141	0.00174	CcSEcCtD
Podofilox—Pain—Chlorambucil—breast cancer	0.00014	0.00173	CcSEcCtD
Podofilox—Haemoglobin—Fluorouracil—breast cancer	0.000139	0.00172	CcSEcCtD
Podofilox—Oedema—Goserelin—breast cancer	0.000139	0.00172	CcSEcCtD
Podofilox—Etoposide—PTGS1—breast cancer	0.000139	0.0276	CrCbGaD
Podofilox—Haemorrhage—Fluorouracil—breast cancer	0.000138	0.00171	CcSEcCtD
Podofilox—Skin disorder—Melphalan—breast cancer	0.000138	0.00171	CcSEcCtD
Podofilox—Inflammation—Epirubicin—breast cancer	0.000138	0.00171	CcSEcCtD
Podofilox—Skin discolouration—Doxorubicin—breast cancer	0.000138	0.0017	CcSEcCtD
Podofilox—Skin exfoliation—Methotrexate—breast cancer	0.000137	0.00169	CcSEcCtD
Podofilox—Vomiting—Anastrozole—breast cancer	0.000135	0.00167	CcSEcCtD
Podofilox—Vomiting—Letrozole—breast cancer	0.000135	0.00167	CcSEcCtD
Podofilox—Skin disorder—Goserelin—breast cancer	0.000135	0.00167	CcSEcCtD
Podofilox—Paraesthesia—Vinblastine—breast cancer	0.000135	0.00166	CcSEcCtD
Podofilox—Rash—Letrozole—breast cancer	0.000134	0.00166	CcSEcCtD
Podofilox—Rash—Anastrozole—breast cancer	0.000134	0.00166	CcSEcCtD
Podofilox—Dermatitis—Letrozole—breast cancer	0.000134	0.00166	CcSEcCtD
Podofilox—Dermatitis—Anastrozole—breast cancer	0.000134	0.00166	CcSEcCtD
Podofilox—Dizziness—Raloxifene—breast cancer	0.000134	0.00165	CcSEcCtD
Podofilox—Headache—Letrozole—breast cancer	0.000133	0.00165	CcSEcCtD
Podofilox—Headache—Anastrozole—breast cancer	0.000133	0.00165	CcSEcCtD
Podofilox—Dry skin—Docetaxel—breast cancer	0.000132	0.00164	CcSEcCtD
Podofilox—Insomnia—Tamoxifen—breast cancer	0.000132	0.00163	CcSEcCtD
Podofilox—Ulcer—Doxorubicin—breast cancer	0.000131	0.00162	CcSEcCtD
Podofilox—Paraesthesia—Tamoxifen—breast cancer	0.000131	0.00162	CcSEcCtD
Podofilox—Immune system disorder—Irinotecan—breast cancer	0.000131	0.00161	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—breast cancer	0.000129	0.00159	CcSEcCtD
Podofilox—Vomiting—Raloxifene—breast cancer	0.000128	0.00159	CcSEcCtD
Podofilox—Vomiting—Idarubicin—breast cancer	0.000128	0.00159	CcSEcCtD
Podofilox—Dry skin—Capecitabine—breast cancer	0.000128	0.00158	CcSEcCtD
Podofilox—Pain—Vinblastine—breast cancer	0.000128	0.00158	CcSEcCtD
Podofilox—Skin exfoliation—Epirubicin—breast cancer	0.000128	0.00158	CcSEcCtD
Podofilox—Inflammation—Doxorubicin—breast cancer	0.000128	0.00158	CcSEcCtD
Podofilox—Paraesthesia—Melphalan—breast cancer	0.000128	0.00158	CcSEcCtD
Podofilox—TOP2A—Vindesine—Vinorelbine—breast cancer	0.000127	0.0441	CbGdCrCtD
Podofilox—Rash—Raloxifene—breast cancer	0.000127	0.00157	CcSEcCtD
Podofilox—Rash—Idarubicin—breast cancer	0.000127	0.00157	CcSEcCtD
Podofilox—Immune system disorder—Gemcitabine—breast cancer	0.000127	0.00157	CcSEcCtD
Podofilox—Dermatitis—Idarubicin—breast cancer	0.000127	0.00157	CcSEcCtD
Podofilox—Dermatitis—Raloxifene—breast cancer	0.000127	0.00157	CcSEcCtD
Podofilox—Headache—Raloxifene—breast cancer	0.000126	0.00156	CcSEcCtD
Podofilox—Headache—Idarubicin—breast cancer	0.000126	0.00156	CcSEcCtD
Podofilox—Erythema—Mitoxantrone—breast cancer	0.000126	0.00156	CcSEcCtD
Podofilox—Insomnia—Goserelin—breast cancer	0.000126	0.00155	CcSEcCtD
Podofilox—Haematuria—Paclitaxel—breast cancer	0.000125	0.00155	CcSEcCtD
Podofilox—Paraesthesia—Goserelin—breast cancer	0.000125	0.00154	CcSEcCtD
Podofilox—Pain—Tamoxifen—breast cancer	0.000124	0.00154	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—breast cancer	0.000123	0.00152	CcSEcCtD
Podofilox—Erythema—Gemcitabine—breast cancer	0.000123	0.00152	CcSEcCtD
Podofilox—Pain—Melphalan—breast cancer	0.000122	0.00151	CcSEcCtD
Podofilox—Skin disorder—Vinorelbine—breast cancer	0.000121	0.0015	CcSEcCtD
Podofilox—Erythema—Fluorouracil—breast cancer	0.000121	0.00149	CcSEcCtD
Podofilox—Pain—Goserelin—breast cancer	0.000119	0.00147	CcSEcCtD
Podofilox—Skin exfoliation—Doxorubicin—breast cancer	0.000119	0.00147	CcSEcCtD
Podofilox—Haemoglobin—Paclitaxel—breast cancer	0.000119	0.00147	CcSEcCtD
Podofilox—Haemorrhage—Paclitaxel—breast cancer	0.000118	0.00146	CcSEcCtD
Podofilox—Pruritus—Chlorambucil—breast cancer	0.000116	0.00143	CcSEcCtD
Podofilox—Skin disorder—Thiotepa—breast cancer	0.000116	0.00143	CcSEcCtD
Podofilox—Paraesthesia—Vinorelbine—breast cancer	0.000112	0.00138	CcSEcCtD
Podofilox—Teniposide—CYP3A4—breast cancer	0.000109	0.0218	CrCbGaD
Podofilox—Paraesthesia—Thiotepa—breast cancer	0.000107	0.00132	CcSEcCtD
Podofilox—Pain—Vinorelbine—breast cancer	0.000106	0.00132	CcSEcCtD
Podofilox—Immune system disorder—Paclitaxel—breast cancer	0.000106	0.00132	CcSEcCtD
Podofilox—Vomiting—Chlorambucil—breast cancer	0.000104	0.00129	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.000104	0.00128	CcSEcCtD
Podofilox—Pruritus—Tamoxifen—breast cancer	0.000103	0.00127	CcSEcCtD
Podofilox—Haematuria—Capecitabine—breast cancer	0.000103	0.00127	CcSEcCtD
Podofilox—Oedema—Mitoxantrone—breast cancer	0.000103	0.00127	CcSEcCtD
Podofilox—Oedema—Irinotecan—breast cancer	0.000103	0.00127	CcSEcCtD
Podofilox—Erythema—Paclitaxel—breast cancer	0.000103	0.00127	CcSEcCtD
Podofilox—Dermatitis bullous—Epirubicin—breast cancer	0.000102	0.00126	CcSEcCtD
Podofilox—TOP2A—Vindesine—Vinblastine—breast cancer	0.000102	0.0352	CbGdCrCtD
Podofilox—Pain—Thiotepa—breast cancer	0.000102	0.00126	CcSEcCtD
Podofilox—Pruritus—Melphalan—breast cancer	0.000101	0.00125	CcSEcCtD
Podofilox—Haemoglobin—Docetaxel—breast cancer	0.0001	0.00124	CcSEcCtD
Podofilox—Oedema—Gemcitabine—breast cancer	0.0001	0.00124	CcSEcCtD
Podofilox—TOP2A—Paclitaxel—Docetaxel—breast cancer	0.0001	0.0346	CbGdCrCtD
Podofilox—Haemorrhage—Docetaxel—breast cancer	9.99e-05	0.00124	CcSEcCtD
Podofilox—Skin disorder—Mitoxantrone—breast cancer	9.98e-05	0.00123	CcSEcCtD
Podofilox—Dizziness—Vinblastine—breast cancer	9.91e-05	0.00123	CcSEcCtD
Podofilox—TUBB—Azacitidine—Gemcitabine—breast cancer	9.9e-05	0.0342	CbGdCrCtD
Podofilox—Pruritus—Goserelin—breast cancer	9.84e-05	0.00122	CcSEcCtD
Podofilox—Oedema—Fluorouracil—breast cancer	9.84e-05	0.00122	CcSEcCtD
Podofilox—Haemoglobin—Capecitabine—breast cancer	9.72e-05	0.0012	CcSEcCtD
Podofilox—Skin disorder—Gemcitabine—breast cancer	9.72e-05	0.0012	CcSEcCtD
Podofilox—Haemorrhage—Capecitabine—breast cancer	9.68e-05	0.0012	CcSEcCtD
Podofilox—Dizziness—Tamoxifen—breast cancer	9.63e-05	0.00119	CcSEcCtD
Podofilox—Vomiting—Vinblastine—breast cancer	9.53e-05	0.00118	CcSEcCtD
Podofilox—Dermatitis bullous—Doxorubicin—breast cancer	9.43e-05	0.00117	CcSEcCtD
Podofilox—Headache—Vinblastine—breast cancer	9.39e-05	0.00116	CcSEcCtD
Podofilox—Insomnia—Irinotecan—breast cancer	9.29e-05	0.00115	CcSEcCtD
Podofilox—Vomiting—Tamoxifen—breast cancer	9.26e-05	0.00114	CcSEcCtD
Podofilox—Paraesthesia—Irinotecan—breast cancer	9.22e-05	0.00114	CcSEcCtD
Podofilox—Paraesthesia—Mitoxantrone—breast cancer	9.22e-05	0.00114	CcSEcCtD
Podofilox—Dizziness—Goserelin—breast cancer	9.2e-05	0.00114	CcSEcCtD
Podofilox—Rash—Tamoxifen—breast cancer	9.18e-05	0.00113	CcSEcCtD
Podofilox—Dermatitis—Tamoxifen—breast cancer	9.17e-05	0.00113	CcSEcCtD
Podofilox—Headache—Tamoxifen—breast cancer	9.12e-05	0.00113	CcSEcCtD
Podofilox—Vomiting—Melphalan—breast cancer	9.06e-05	0.00112	CcSEcCtD
Podofilox—Insomnia—Gemcitabine—breast cancer	9.05e-05	0.00112	CcSEcCtD
Podofilox—Immune system disorder—Docetaxel—breast cancer	9.03e-05	0.00112	CcSEcCtD
Podofilox—Rash—Melphalan—breast cancer	8.99e-05	0.00111	CcSEcCtD
Podofilox—Paraesthesia—Gemcitabine—breast cancer	8.98e-05	0.00111	CcSEcCtD
Podofilox—Dermatitis—Melphalan—breast cancer	8.98e-05	0.00111	CcSEcCtD
Podofilox—Dry skin—Epirubicin—breast cancer	8.93e-05	0.0011	CcSEcCtD
Podofilox—Insomnia—Fluorouracil—breast cancer	8.9e-05	0.0011	CcSEcCtD
Podofilox—Vomiting—Goserelin—breast cancer	8.84e-05	0.00109	CcSEcCtD
Podofilox—Paraesthesia—Fluorouracil—breast cancer	8.83e-05	0.00109	CcSEcCtD
Podofilox—Pruritus—Vinorelbine—breast cancer	8.81e-05	0.00109	CcSEcCtD
Podofilox—Pain—Irinotecan—breast cancer	8.78e-05	0.00109	CcSEcCtD
Podofilox—Pain—Mitoxantrone—breast cancer	8.78e-05	0.00109	CcSEcCtD
Podofilox—Rash—Goserelin—breast cancer	8.77e-05	0.00108	CcSEcCtD
Podofilox—Dermatitis—Goserelin—breast cancer	8.76e-05	0.00108	CcSEcCtD
Podofilox—Immune system disorder—Capecitabine—breast cancer	8.74e-05	0.00108	CcSEcCtD
Podofilox—Headache—Goserelin—breast cancer	8.71e-05	0.00108	CcSEcCtD
Podofilox—Erythema—Docetaxel—breast cancer	8.7e-05	0.00108	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	8.68e-05	0.00107	CcSEcCtD
Podofilox—Pain—Gemcitabine—breast cancer	8.56e-05	0.00106	CcSEcCtD
Podofilox—Erythema—Capecitabine—breast cancer	8.42e-05	0.00104	CcSEcCtD
Podofilox—Pruritus—Thiotepa—breast cancer	8.41e-05	0.00104	CcSEcCtD
Podofilox—Pain—Fluorouracil—breast cancer	8.41e-05	0.00104	CcSEcCtD
Podofilox—Oedema—Paclitaxel—breast cancer	8.38e-05	0.00104	CcSEcCtD
Podofilox—Dry skin—Doxorubicin—breast cancer	8.26e-05	0.00102	CcSEcCtD
Podofilox—Dizziness—Vinorelbine—breast cancer	8.24e-05	0.00102	CcSEcCtD
Podofilox—Skin disorder—Paclitaxel—breast cancer	8.14e-05	0.00101	CcSEcCtD
Podofilox—Etoposide—CYP3A4—breast cancer	8.1e-05	0.0161	CrCbGaD
Podofilox—Etoposide—PTGS2—breast cancer	7.93e-05	0.0158	CrCbGaD
Podofilox—Vomiting—Vinorelbine—breast cancer	7.92e-05	0.000979	CcSEcCtD
Podofilox—Dizziness—Thiotepa—breast cancer	7.86e-05	0.000972	CcSEcCtD
Podofilox—Rash—Vinorelbine—breast cancer	7.85e-05	0.000971	CcSEcCtD
Podofilox—Dermatitis—Vinorelbine—breast cancer	7.85e-05	0.00097	CcSEcCtD
Podofilox—Headache—Vinorelbine—breast cancer	7.8e-05	0.000965	CcSEcCtD
Podofilox—Haematuria—Methotrexate—breast cancer	7.65e-05	0.000946	CcSEcCtD
Podofilox—Insomnia—Paclitaxel—breast cancer	7.58e-05	0.000937	CcSEcCtD
Podofilox—Vomiting—Thiotepa—breast cancer	7.56e-05	0.000935	CcSEcCtD
Podofilox—Paraesthesia—Paclitaxel—breast cancer	7.52e-05	0.00093	CcSEcCtD
Podofilox—Rash—Thiotepa—breast cancer	7.5e-05	0.000927	CcSEcCtD
Podofilox—Dermatitis—Thiotepa—breast cancer	7.49e-05	0.000926	CcSEcCtD
Podofilox—Headache—Thiotepa—breast cancer	7.45e-05	0.000921	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	7.36e-05	0.000909	CcSEcCtD
Podofilox—TOP2A—Doxorubicin—Idarubicin—breast cancer	7.3e-05	0.0252	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Idarubicin—breast cancer	7.3e-05	0.0252	CbGdCrCtD
Podofilox—TOP2A—Epirubicin—Idarubicin—breast cancer	7.3e-05	0.0252	CbGdCrCtD
Podofilox—Haemoglobin—Methotrexate—breast cancer	7.24e-05	0.000895	CcSEcCtD
Podofilox—Haemorrhage—Methotrexate—breast cancer	7.2e-05	0.00089	CcSEcCtD
Podofilox—Pain—Paclitaxel—breast cancer	7.16e-05	0.000886	CcSEcCtD
Podofilox—Haematuria—Epirubicin—breast cancer	7.16e-05	0.000885	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	7.12e-05	0.00088	CcSEcCtD
Podofilox—Oedema—Docetaxel—breast cancer	7.1e-05	0.000878	CcSEcCtD
Podofilox—Pruritus—Gemcitabine—breast cancer	7.08e-05	0.000875	CcSEcCtD
Podofilox—Pruritus—Fluorouracil—breast cancer	6.96e-05	0.00086	CcSEcCtD
Podofilox—Skin disorder—Docetaxel—breast cancer	6.9e-05	0.000853	CcSEcCtD
Podofilox—TOP2A—Vincristine—Vinorelbine—breast cancer	6.87e-05	0.0238	CbGdCrCtD
Podofilox—Oedema—Capecitabine—breast cancer	6.87e-05	0.00085	CcSEcCtD
Podofilox—Dizziness—Irinotecan—breast cancer	6.79e-05	0.00084	CcSEcCtD
Podofilox—Haemoglobin—Epirubicin—breast cancer	6.77e-05	0.000838	CcSEcCtD
Podofilox—Etoposide—ABCB1—breast cancer	6.75e-05	0.0134	CrCbGaD
Podofilox—Haemorrhage—Epirubicin—breast cancer	6.74e-05	0.000833	CcSEcCtD
Podofilox—Skin disorder—Capecitabine—breast cancer	6.68e-05	0.000825	CcSEcCtD
Podofilox—Haematuria—Doxorubicin—breast cancer	6.62e-05	0.000819	CcSEcCtD
Podofilox—Vomiting—Mitoxantrone—breast cancer	6.53e-05	0.000807	CcSEcCtD
Podofilox—Vomiting—Irinotecan—breast cancer	6.53e-05	0.000807	CcSEcCtD
Podofilox—Immune system disorder—Methotrexate—breast cancer	6.51e-05	0.000804	CcSEcCtD
Podofilox—Dizziness—Fluorouracil—breast cancer	6.51e-05	0.000804	CcSEcCtD
Podofilox—Rash—Irinotecan—breast cancer	6.48e-05	0.000801	CcSEcCtD
Podofilox—Rash—Mitoxantrone—breast cancer	6.48e-05	0.000801	CcSEcCtD
Podofilox—Dermatitis—Mitoxantrone—breast cancer	6.47e-05	0.0008	CcSEcCtD
Podofilox—Dermatitis—Irinotecan—breast cancer	6.47e-05	0.0008	CcSEcCtD
Podofilox—Headache—Irinotecan—breast cancer	6.43e-05	0.000795	CcSEcCtD
Podofilox—Headache—Mitoxantrone—breast cancer	6.43e-05	0.000795	CcSEcCtD
Podofilox—TOP2A—Vinorelbine—Vinblastine—breast cancer	6.43e-05	0.0222	CbGdCrCtD
Podofilox—Insomnia—Docetaxel—breast cancer	6.42e-05	0.000794	CcSEcCtD
Podofilox—Paraesthesia—Docetaxel—breast cancer	6.38e-05	0.000788	CcSEcCtD
Podofilox—Vomiting—Gemcitabine—breast cancer	6.36e-05	0.000786	CcSEcCtD
Podofilox—Rash—Gemcitabine—breast cancer	6.31e-05	0.00078	CcSEcCtD
Podofilox—Dermatitis—Gemcitabine—breast cancer	6.3e-05	0.000779	CcSEcCtD
Podofilox—Erythema—Methotrexate—breast cancer	6.27e-05	0.000775	CcSEcCtD
Podofilox—Haemoglobin—Doxorubicin—breast cancer	6.27e-05	0.000775	CcSEcCtD
Podofilox—Headache—Gemcitabine—breast cancer	6.27e-05	0.000775	CcSEcCtD
Podofilox—Vomiting—Fluorouracil—breast cancer	6.25e-05	0.000773	CcSEcCtD
Podofilox—Haemorrhage—Doxorubicin—breast cancer	6.24e-05	0.000771	CcSEcCtD
Podofilox—Insomnia—Capecitabine—breast cancer	6.22e-05	0.000769	CcSEcCtD
Podofilox—Rash—Fluorouracil—breast cancer	6.2e-05	0.000767	CcSEcCtD
Podofilox—Dermatitis—Fluorouracil—breast cancer	6.2e-05	0.000766	CcSEcCtD
Podofilox—Paraesthesia—Capecitabine—breast cancer	6.17e-05	0.000763	CcSEcCtD
Podofilox—Headache—Fluorouracil—breast cancer	6.16e-05	0.000762	CcSEcCtD
Podofilox—Immune system disorder—Epirubicin—breast cancer	6.09e-05	0.000753	CcSEcCtD
Podofilox—Pain—Docetaxel—breast cancer	6.07e-05	0.000751	CcSEcCtD
Podofilox—Pruritus—Paclitaxel—breast cancer	5.93e-05	0.000733	CcSEcCtD
Podofilox—Pain—Capecitabine—breast cancer	5.88e-05	0.000727	CcSEcCtD
Podofilox—Erythema—Epirubicin—breast cancer	5.87e-05	0.000725	CcSEcCtD
Podofilox—Immune system disorder—Doxorubicin—breast cancer	5.63e-05	0.000696	CcSEcCtD
Podofilox—Dizziness—Paclitaxel—breast cancer	5.54e-05	0.000685	CcSEcCtD
Podofilox—TOP2A—Vinblastine—Vinorelbine—breast cancer	5.53e-05	0.0191	CbGdCrCtD
Podofilox—TOP2A—Vincristine—Vinblastine—breast cancer	5.5e-05	0.019	CbGdCrCtD
Podofilox—Erythema—Doxorubicin—breast cancer	5.43e-05	0.000671	CcSEcCtD
Podofilox—Vomiting—Paclitaxel—breast cancer	5.33e-05	0.000658	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.3e-05	0.000655	CcSEcCtD
Podofilox—Rash—Paclitaxel—breast cancer	5.28e-05	0.000653	CcSEcCtD
Podofilox—Dermatitis—Paclitaxel—breast cancer	5.28e-05	0.000652	CcSEcCtD
Podofilox—Headache—Paclitaxel—breast cancer	5.25e-05	0.000649	CcSEcCtD
Podofilox—Pruritus—Docetaxel—breast cancer	5.02e-05	0.000621	CcSEcCtD
Podofilox—Skin disorder—Methotrexate—breast cancer	4.97e-05	0.000614	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.96e-05	0.000613	CcSEcCtD
Podofilox—Pruritus—Capecitabine—breast cancer	4.86e-05	0.000601	CcSEcCtD
Podofilox—Oedema—Epirubicin—breast cancer	4.79e-05	0.000592	CcSEcCtD
Podofilox—Dizziness—Docetaxel—breast cancer	4.7e-05	0.00058	CcSEcCtD
Podofilox—Skin disorder—Epirubicin—breast cancer	4.65e-05	0.000575	CcSEcCtD
Podofilox—Insomnia—Methotrexate—breast cancer	4.63e-05	0.000572	CcSEcCtD
Podofilox—TOP2A—Methyltestosterone—Fluoxymesterone—breast cancer	4.63e-05	0.016	CbGdCrCtD
Podofilox—Paraesthesia—Methotrexate—breast cancer	4.6e-05	0.000568	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.59e-05	0.000568	CcSEcCtD
Podofilox—Dizziness—Capecitabine—breast cancer	4.55e-05	0.000562	CcSEcCtD
Podofilox—Vomiting—Docetaxel—breast cancer	4.51e-05	0.000558	CcSEcCtD
Podofilox—Rash—Docetaxel—breast cancer	4.48e-05	0.000553	CcSEcCtD
Podofilox—Dermatitis—Docetaxel—breast cancer	4.47e-05	0.000553	CcSEcCtD
Podofilox—Headache—Docetaxel—breast cancer	4.45e-05	0.00055	CcSEcCtD
Podofilox—Oedema—Doxorubicin—breast cancer	4.43e-05	0.000548	CcSEcCtD
Podofilox—Pain—Methotrexate—breast cancer	4.38e-05	0.000541	CcSEcCtD
Podofilox—Vomiting—Capecitabine—breast cancer	4.37e-05	0.00054	CcSEcCtD
Podofilox—Rash—Capecitabine—breast cancer	4.33e-05	0.000536	CcSEcCtD
Podofilox—Insomnia—Epirubicin—breast cancer	4.33e-05	0.000535	CcSEcCtD
Podofilox—Dermatitis—Capecitabine—breast cancer	4.33e-05	0.000535	CcSEcCtD
Podofilox—Headache—Capecitabine—breast cancer	4.31e-05	0.000532	CcSEcCtD
Podofilox—Skin disorder—Doxorubicin—breast cancer	4.3e-05	0.000532	CcSEcCtD
Podofilox—Paraesthesia—Epirubicin—breast cancer	4.3e-05	0.000532	CcSEcCtD
Podofilox—Pain—Epirubicin—breast cancer	4.1e-05	0.000506	CcSEcCtD
Podofilox—Insomnia—Doxorubicin—breast cancer	4.01e-05	0.000495	CcSEcCtD
Podofilox—Paraesthesia—Doxorubicin—breast cancer	3.98e-05	0.000492	CcSEcCtD
Podofilox—Pain—Doxorubicin—breast cancer	3.79e-05	0.000468	CcSEcCtD
Podofilox—Pruritus—Methotrexate—breast cancer	3.62e-05	0.000448	CcSEcCtD
Podofilox—TOP2A—Cytarabine—Gemcitabine—breast cancer	3.61e-05	0.0125	CbGdCrCtD
Podofilox—Pruritus—Epirubicin—breast cancer	3.39e-05	0.000419	CcSEcCtD
Podofilox—Dizziness—Methotrexate—breast cancer	3.38e-05	0.000418	CcSEcCtD
Podofilox—TOP2A—Idarubicin—Epirubicin—breast cancer	3.35e-05	0.0116	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Epirubicin—breast cancer	3.35e-05	0.0116	CbGdCrCtD
Podofilox—TOP2A—Doxorubicin—Epirubicin—breast cancer	3.35e-05	0.0116	CbGdCrCtD
Podofilox—Vomiting—Methotrexate—breast cancer	3.25e-05	0.000402	CcSEcCtD
Podofilox—Rash—Methotrexate—breast cancer	3.23e-05	0.000399	CcSEcCtD
Podofilox—Dermatitis—Methotrexate—breast cancer	3.22e-05	0.000399	CcSEcCtD
Podofilox—Headache—Methotrexate—breast cancer	3.21e-05	0.000396	CcSEcCtD
Podofilox—Dizziness—Epirubicin—breast cancer	3.17e-05	0.000392	CcSEcCtD
Podofilox—Pruritus—Doxorubicin—breast cancer	3.14e-05	0.000388	CcSEcCtD
Podofilox—TOP2A—Idarubicin—Doxorubicin—breast cancer	3.1e-05	0.0107	CbGdCrCtD
Podofilox—TOP2A—Epirubicin—Doxorubicin—breast cancer	3.1e-05	0.0107	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Doxorubicin—breast cancer	3.1e-05	0.0107	CbGdCrCtD
Podofilox—Vomiting—Epirubicin—breast cancer	3.04e-05	0.000376	CcSEcCtD
Podofilox—Rash—Epirubicin—breast cancer	3.02e-05	0.000373	CcSEcCtD
Podofilox—Dermatitis—Epirubicin—breast cancer	3.02e-05	0.000373	CcSEcCtD
Podofilox—TOP2A—Norethindrone—Fluoxymesterone—breast cancer	3.02e-05	0.0104	CbGdCrCtD
Podofilox—Headache—Epirubicin—breast cancer	3e-05	0.000371	CcSEcCtD
Podofilox—Dizziness—Doxorubicin—breast cancer	2.93e-05	0.000362	CcSEcCtD
Podofilox—Vomiting—Doxorubicin—breast cancer	2.82e-05	0.000348	CcSEcCtD
Podofilox—Rash—Doxorubicin—breast cancer	2.79e-05	0.000345	CcSEcCtD
Podofilox—Dermatitis—Doxorubicin—breast cancer	2.79e-05	0.000345	CcSEcCtD
Podofilox—Headache—Doxorubicin—breast cancer	2.78e-05	0.000343	CcSEcCtD
Podofilox—TOP2A—Azacitidine—Gemcitabine—breast cancer	2.59e-05	0.00895	CbGdCrCtD
Podofilox—TOP2A—Cell Cycle—MDM2—breast cancer	9.81e-06	0.000132	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MYC—breast cancer	9.8e-06	0.000132	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—MED12—breast cancer	9.7e-06	0.000131	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—HRAS—breast cancer	9.6e-06	0.000129	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CCND1—breast cancer	9.56e-06	0.000129	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CHST9—breast cancer	9.48e-06	0.000128	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—breast cancer	9.47e-06	0.000128	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—COMT—breast cancer	9.35e-06	0.000126	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTP1—breast cancer	9.31e-06	0.000125	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—ESR1—breast cancer	9.27e-06	0.000125	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	9.27e-06	0.000125	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN1A—breast cancer	9.25e-06	0.000125	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—COMT—breast cancer	9.22e-06	0.000124	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	9.18e-06	0.000124	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NOTCH4—breast cancer	9.14e-06	0.000123	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	9.01e-06	0.000122	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—COX11—breast cancer	8.99e-06	0.000121	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NOTCH1—breast cancer	8.96e-06	0.000121	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN1B—breast cancer	8.96e-06	0.000121	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	8.84e-06	0.000119	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HSPA1B—breast cancer	8.72e-06	0.000118	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL6—breast cancer	8.58e-06	0.000116	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—breast cancer	8.57e-06	0.000116	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTM1—breast cancer	8.55e-06	0.000115	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CCND1—breast cancer	8.55e-06	0.000115	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—AKT1—breast cancer	8.47e-06	0.000114	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	8.43e-06	0.000114	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PGR—breast cancer	8.36e-06	0.000113	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN1A—breast cancer	8.27e-06	0.000111	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SHMT1—breast cancer	8.22e-06	0.000111	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CDA—breast cancer	8.22e-06	0.000111	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—DNMT1—breast cancer	8.2e-06	0.000111	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	8.12e-06	0.000109	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP1A1—breast cancer	8.11e-06	0.000109	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—breast cancer	8.05e-06	0.000109	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NCOA2—breast cancer	8.05e-06	0.000108	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	8.03e-06	0.000108	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	8e-06	0.000108	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—EZH2—breast cancer	7.94e-06	0.000107	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLCO1B1—breast cancer	7.91e-06	0.000107	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC2A5—breast cancer	7.91e-06	0.000107	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MAPK3—breast cancer	7.88e-06	0.000106	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NOTCH3—breast cancer	7.77e-06	0.000105	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PARP1—breast cancer	7.77e-06	0.000105	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	7.73e-06	0.000104	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MYC—breast cancer	7.67e-06	0.000103	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APRT—breast cancer	7.64e-06	0.000103	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—SERPINE1—breast cancer	7.62e-06	0.000103	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—RPS6—breast cancer	7.59e-06	0.000102	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—FASN—breast cancer	7.5e-06	0.000101	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—breast cancer	7.47e-06	0.000101	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ESR2—breast cancer	7.36e-06	9.92e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ESRRA—breast cancer	7.19e-06	9.69e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ANGPTL4—breast cancer	7.19e-06	9.69e-05	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MAPK3—breast cancer	7.05e-06	9.5e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NOTCH2—breast cancer	6.97e-06	9.4e-05	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MYC—breast cancer	6.86e-06	9.24e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	6.83e-06	9.21e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HADHB—breast cancer	6.81e-06	9.18e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GPI—breast cancer	6.81e-06	9.18e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NCOA1—breast cancer	6.78e-06	9.14e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SYNJ2—breast cancer	6.52e-06	8.79e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	6.52e-06	8.78e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AR—breast cancer	6.5e-06	8.76e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALDH7A1—breast cancer	6.5e-06	8.76e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALDH1A1—breast cancer	6.5e-06	8.76e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	6.42e-06	8.66e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—FHL2—breast cancer	6.23e-06	8.4e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PHGDH—breast cancer	6.23e-06	8.4e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—UMPS—breast cancer	6.23e-06	8.4e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NME1—breast cancer	6.23e-06	8.4e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ADSL—breast cancer	6.23e-06	8.4e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—BRIP1—breast cancer	6.11e-06	8.24e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HPSE—breast cancer	6.11e-06	8.24e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—LDHB—breast cancer	6.11e-06	8.24e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NDUFS3—breast cancer	6.06e-06	8.17e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SIRT1—breast cancer	5.93e-06	7.99e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SMAD4—breast cancer	5.85e-06	7.89e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—VDR—breast cancer	5.84e-06	7.87e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCC1—breast cancer	5.79e-06	7.81e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HMMR—breast cancer	5.79e-06	7.81e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA3—breast cancer	5.79e-06	7.81e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CHST9—breast cancer	5.7e-06	7.69e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NCOR1—breast cancer	5.68e-06	7.66e-05	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—breast cancer	5.63e-06	7.59e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPARGC1B—breast cancer	5.61e-06	7.56e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—H2AFX—breast cancer	5.54e-06	7.47e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	5.46e-06	7.36e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	5.46e-06	7.36e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—COX11—breast cancer	5.4e-06	7.29e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ERCC2—breast cancer	5.34e-06	7.2e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CA9—breast cancer	5.3e-06	7.14e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA4—breast cancer	5.3e-06	7.14e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—breast cancer	5.23e-06	7.05e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	5.18e-06	6.98e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GPX2—breast cancer	5.16e-06	6.96e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA2—breast cancer	5.16e-06	6.96e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GPX4—breast cancer	5.1e-06	6.87e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SULT1A1—breast cancer	5.1e-06	6.87e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—IDH1—breast cancer	4.98e-06	6.71e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA1—breast cancer	4.98e-06	6.71e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SHMT1—breast cancer	4.94e-06	6.66e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CDA—breast cancer	4.94e-06	6.66e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NAT2—breast cancer	4.92e-06	6.64e-05	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MYC—breast cancer	4.82e-06	6.5e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLCO1B1—breast cancer	4.76e-06	6.41e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC2A5—breast cancer	4.76e-06	6.41e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APRT—breast cancer	4.6e-06	6.19e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ESR1—breast cancer	4.46e-06	6.02e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—breast cancer	4.45e-06	6e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ANGPTL4—breast cancer	4.32e-06	5.82e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ESRRA—breast cancer	4.32e-06	5.82e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MED12—breast cancer	4.32e-06	5.82e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—DPYD—breast cancer	4.32e-06	5.82e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NOTCH1—breast cancer	4.32e-06	5.82e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALDOA—breast cancer	4.25e-06	5.73e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NCOA3—breast cancer	4.13e-06	5.56e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC2A2—breast cancer	4.1e-06	5.52e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GPI—breast cancer	4.1e-06	5.52e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HADHB—breast cancer	4.1e-06	5.52e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.06e-06	5.47e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CPT1A—breast cancer	4.01e-06	5.41e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MTR—breast cancer	4.01e-06	5.41e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCG2—breast cancer	4.01e-06	5.41e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HPGDS—breast cancer	3.94e-06	5.31e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HBA1—breast cancer	3.91e-06	5.27e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALDH7A1—breast cancer	3.91e-06	5.27e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALDH1A1—breast cancer	3.91e-06	5.27e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ACHE—breast cancer	3.82e-06	5.15e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTT1—breast cancer	3.82e-06	5.15e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PHGDH—breast cancer	3.75e-06	5.05e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NME1—breast cancer	3.75e-06	5.05e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—FHL2—breast cancer	3.75e-06	5.05e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—UMPS—breast cancer	3.75e-06	5.05e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ADSL—breast cancer	3.75e-06	5.05e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—LDHB—breast cancer	3.67e-06	4.95e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HPSE—breast cancer	3.67e-06	4.95e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—BRIP1—breast cancer	3.67e-06	4.95e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SERPINE1—breast cancer	3.67e-06	4.95e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP17A1—breast cancer	3.61e-06	4.87e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ENO1—breast cancer	3.58e-06	4.82e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS1—breast cancer	3.58e-06	4.82e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.56e-06	4.81e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.52e-06	4.74e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP2D6—breast cancer	3.51e-06	4.73e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA3—breast cancer	3.48e-06	4.69e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCC1—breast cancer	3.48e-06	4.69e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HMMR—breast cancer	3.48e-06	4.69e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NCOA2—breast cancer	3.44e-06	4.64e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPARGC1B—breast cancer	3.37e-06	4.55e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—FASN—breast cancer	3.34e-06	4.5e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—BCHE—breast cancer	3.33e-06	4.48e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC5A5—breast cancer	3.29e-06	4.43e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA4—breast cancer	3.19e-06	4.29e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CA9—breast cancer	3.19e-06	4.29e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC2A1—breast cancer	3.17e-06	4.28e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NQO1—breast cancer	3.17e-06	4.28e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.11e-06	4.19e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA2—breast cancer	3.1e-06	4.18e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GPX2—breast cancer	3.1e-06	4.18e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP3A4—breast cancer	3.09e-06	4.17e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.08e-06	4.15e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GPX4—breast cancer	3.07e-06	4.13e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SULT1A1—breast cancer	3.07e-06	4.13e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP1B1—breast cancer	3.04e-06	4.1e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—IDH1—breast cancer	2.99e-06	4.04e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA1—breast cancer	2.99e-06	4.04e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HSP90AA1—breast cancer	2.98e-06	4.02e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NAT2—breast cancer	2.96e-06	3.99e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NCOA1—breast cancer	2.9e-06	3.91e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—STK11—breast cancer	2.86e-06	3.86e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP19A1—breast cancer	2.86e-06	3.86e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.69e-06	3.62e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—COMT—breast cancer	2.66e-06	3.58e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTP1—breast cancer	2.65e-06	3.57e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HMOX1—breast cancer	2.61e-06	3.52e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ITPR1—breast cancer	2.6e-06	3.51e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—DPYD—breast cancer	2.6e-06	3.5e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MED12—breast cancer	2.6e-06	3.5e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALDOA—breast cancer	2.56e-06	3.45e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCB1—breast cancer	2.51e-06	3.38e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NCOA3—breast cancer	2.48e-06	3.35e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC2A2—breast cancer	2.46e-06	3.32e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TYMS—breast cancer	2.46e-06	3.32e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NCOR1—breast cancer	2.43e-06	3.28e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTM1—breast cancer	2.43e-06	3.28e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.43e-06	3.28e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MTR—breast cancer	2.41e-06	3.25e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CPT1A—breast cancer	2.41e-06	3.25e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCG2—breast cancer	2.41e-06	3.25e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MAPK3—breast cancer	2.39e-06	3.22e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HPGDS—breast cancer	2.37e-06	3.19e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HBA1—breast cancer	2.35e-06	3.17e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GPX1—breast cancer	2.33e-06	3.14e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MYC—breast cancer	2.32e-06	3.13e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP1A1—breast cancer	2.31e-06	3.11e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTT1—breast cancer	2.3e-06	3.1e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ACHE—breast cancer	2.3e-06	3.1e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ERCC2—breast cancer	2.29e-06	3.08e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP17A1—breast cancer	2.17e-06	2.93e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ENO1—breast cancer	2.15e-06	2.9e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS1—breast cancer	2.15e-06	2.9e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MTHFR—breast cancer	2.15e-06	2.9e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP2D6—breast cancer	2.11e-06	2.84e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NCOA2—breast cancer	2.07e-06	2.79e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—FASN—breast cancer	2.01e-06	2.71e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—BCHE—breast cancer	2e-06	2.7e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CAV1—breast cancer	1.98e-06	2.67e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC5A5—breast cancer	1.98e-06	2.66e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC2A1—breast cancer	1.91e-06	2.57e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NQO1—breast cancer	1.91e-06	2.57e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.89e-06	2.55e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP1B1—breast cancer	1.83e-06	2.47e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CG—breast cancer	1.81e-06	2.43e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.79e-06	2.42e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NCOA1—breast cancer	1.75e-06	2.35e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—STK11—breast cancer	1.72e-06	2.32e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP19A1—breast cancer	1.72e-06	2.32e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AKT1—breast cancer	1.61e-06	2.17e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—COMT—breast cancer	1.6e-06	2.16e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTP1—breast cancer	1.59e-06	2.15e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CD—breast cancer	1.59e-06	2.14e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HMOX1—breast cancer	1.57e-06	2.12e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALB—breast cancer	1.57e-06	2.11e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ITPR1—breast cancer	1.57e-06	2.11e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCB1—breast cancer	1.51e-06	2.03e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NOS3—breast cancer	1.5e-06	2.02e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TYMS—breast cancer	1.48e-06	1.99e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.46e-06	1.97e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTM1—breast cancer	1.46e-06	1.97e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NCOR1—breast cancer	1.46e-06	1.97e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GPX1—breast cancer	1.4e-06	1.89e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP1A1—breast cancer	1.39e-06	1.87e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CB—breast cancer	1.38e-06	1.87e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ERCC2—breast cancer	1.38e-06	1.85e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS2—breast cancer	1.37e-06	1.85e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MTHFR—breast cancer	1.29e-06	1.74e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTEN—breast cancer	1.2e-06	1.61e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CAV1—breast cancer	1.19e-06	1.61e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CG—breast cancer	1.09e-06	1.46e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CD—breast cancer	9.55e-07	1.29e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALB—breast cancer	9.42e-07	1.27e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NOS3—breast cancer	9.02e-07	1.22e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CA—breast cancer	8.44e-07	1.14e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CB—breast cancer	8.32e-07	1.12e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS2—breast cancer	8.25e-07	1.11e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTEN—breast cancer	7.19e-07	9.69e-06	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AKT1—breast cancer	6.89e-07	9.29e-06	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CA—breast cancer	5.07e-07	6.84e-06	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AKT1—breast cancer	4.14e-07	5.59e-06	CbGpPWpGaD
